WIA
CALC icon

Wealthedge Investment Advisors’s CalciMedica CALC Stock Holding History

Wealthedge Investment Advisors’s Portfolio CALC Stock Details CALC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-17,494
Closed -$140K – 132
2025
Q2 		$140K Sell
17,494
-4,164
-19% -$35.7K 0.06% 139
2025
Q1 		$207K Buy
21,658
+16,094
+289% +$201K 0.09% 154
2024
Q4 		$98.5K Buy
+5,564
New +$97.5K 0.04% 160

Other funds holding CALC

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.9% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return
SFFS
Stonehage Fleming Financial Services St. Helier, Jersey $2.93B AUM 16.25% 1-Year Est. Return
SSIM
Sheets Smith Investment Management Houston, Texas $154M AUM 66.97% 1-Year Est. Return

Wealthedge Investment Advisors's CALC Position: Q3 2025 in Review

Wealthedge Investment Advisors sold out of CalciMedica (CALC) in Q3 2025, closing a stake of 17,494 shares — an estimated $140K sold.

Wealthedge Investment Advisors first reported a position in CALC in Q4 2024 and held it in 3 quarters. The position peaked at $207K in Q1 2025. 31 funds tracked by Wall St. Rank hold CALC as of Q3 2025.

  • Wealthedge Investment Advisors reported no remaining CalciMedica position as of Q3 2025 after selling out during the quarter.
  • Wealthedge Investment Advisors sold 17,494 CalciMedica shares in Q3 2025, an estimated $140K.
  • Wealthedge Investment Advisors first reported a position in CalciMedica in Q4 2024 and held it in 3 quarters.
  • Wealthedge Investment Advisors's CalciMedica position peaked at $207K in Q1 2025.
  • 31 funds tracked by Wall St. Rank held CalciMedica as of Q3 2025.

Based on Wealthedge Investment Advisors's 13F filing for Q3 2025, filed 12 Nov 2025.